top of page

Lighthouse
How Does Awareness of Biomarkers Compare to Prevalence?
We compared awareness in oncologists of selected biomarkers to the prevalence of actionable oncogenic mutations across cancers.

Lighthouse
Trending and Awareness for Merkel Cell Carcinoma
We evaluated trending and awareness for MCC in oncologists and dermatologists over the past decade and found spikes align with treatments.

Lighthouse
NTRK Trending and Awareness in Community Oncologists
We analyzed trending and awareness patterns of NTRK and NTRK-targeting compounds in academic and community oncologists.
bottom of page